RMTC Completes Analysis Of HISA Withdrawal Guidance

Sarah Andrew Photo

The Racing Medication and Testing Consortium's Scientific Advisory Committee has now completed its analysis of HISA's proposed ADMC screening limits and detection times and has developed a withdrawal guidance limited to RMTC's schedule of Controlled Therapeutic Substances. This withdrawal guidance is based on existing research and administration data. The complete withdrawal guidance, which is subject to change, can be found here.

The intention is for the RMTC to provide the industry with scientifically derived information to aid attending veterinarians and horsemen in making medication decisions and to avoid preventable errors, promote compliance with HISA's regulations, and provide all available information in advance of HISA's expected ADMC implementation date of March 27.

Not a subscriber? Click here to sign up for the daily PDF or alerts.

Copy Article Link

Liked this article? Read more like this.

  1. Santa Anita Concludes Winter-Spring Season With 99.97% Safety Record
  2. Week In Review: Northern California Racing Begins Its Uphill Battle For Survival
  3. Letter To The Editor: Why Calls For Synthetic Racing Surfaces Aren't Hysterical
  4. Tickets On Sale For Horse Racing Women's Summit Event At Saratoga
  5. Q and A With David Ingordo on the HISA Horsemen's Advisory Group
X

Never miss another story from the TDN

Click Here to sign up for a free subscription.